Case 1 – Response to imatinib re-challenge in recurrent pigmented villonodular synovitis (PVNS)

 

Authors

  • E. Palesandro Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (Torino), Italy.
  • P. Boccone Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (Torino), Italy.
  • D. Galizia Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (Torino), Italy.
  • I. Bertotto Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (Torino), Italy.
  • Silvia Stacchiotti Adult Mesenchymal Tumor Medical Oncology Unit Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Keywords:

bariatric surgery, imatinib, pigmented villonodular synovitis

Abstract

Pigmented villonodular synovitis (PVNS) is a rare, locally-aggressive tumor arising from synovial membrane and characterized by a specific t(1;2) translocation resulting in CSF1 overexpression. This case report describes the unusual case of a young woman, with obesity as the only relevant comorbidity, with a relapsed PVNS of the left knee successfully treated with imatinib.

Downloads

Published

2015-11-15

How to Cite

1.
Palesandro E, Boccone P, Galizia D, Bertotto I, Stacchiotti S. Case 1 – Response to imatinib re-challenge in recurrent pigmented villonodular synovitis (PVNS):  . CBN [Internet]. 2015 Nov. 15 [cited 2024 Jul. 3];3(2):35-9. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/242

Issue

Vol. 3 No. 2 (2015): November 2015

Section

Meet the expert

License

Articles published in Cancer Breaking News are distributed under the CC Attribution-NonCommercial-NoDerivatives 4.0 license, which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.